Okino T - Search Results

1

[Clinical therapeutic effect of adoptive immunotherapy using IL-2-cultured autologous lymphocytes].

Kan N, Okino T, Nakanishi M, Satou K, Mise K, Ohgaki K, Hori T, Kodama H, Tobe T. Kan N, et al. Among authors: okino t. Hum Cell. 1988 Sep;1(3):289-96. Hum Cell. 1988. PMID: 2979206 Japanese.

2

Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusion.

Hori T, Mise K, Kan N, Okino T, Satoh K, Yamasaki S, Teramura Y, Harada T, Ohgaki K, Kodama H, et al. Hori T, et al. Among authors: okino t. Biotherapy. 1992;5(1):21-9. doi: 10.1007/BF02194783. Biotherapy. 1992. PMID: 1389900

3

Factors influencing the response and survival of patients with liver metastases from breast cancer receiving OK-432-combined adoptive immunotherapy.

Yamasaki S, Okino T, Kan N, Satoh K, Mise K, Teramura Y, Harada T, Kodama H, Hori T, Ohgaki K, et al. Yamasaki S, et al. Among authors: okino t. J Cancer Res Clin Oncol. 1992;118(2):157-62. doi: 10.1007/BF01187506. J Cancer Res Clin Oncol. 1992. PMID: 1735736

4

A murine plasmacytoma MOPC 104E resistant to cyclophosphamide is resistant to immunotherapy.

Satoh K, Kan N, Okino T, Nakanishi M, Mise K, Teramura Y, Yamasaki S, Ohgaki K, Tobe T. Satoh K, et al. Among authors: okino t. Cancer Immunol Immunother. 1991;32(5):273-9. doi: 10.1007/BF01789044. Cancer Immunol Immunother. 1991. PMID: 1998969 Free PMC article.

5

Comparison between crude interleukin-2 and recombinant interleukin-2 in maintaining killing activity of cultured lymphocytes.

Nakanishi M, Kan N, Okino T, Satoh K, Mise K, Teramura Y, Yamasaki S, Ohgaki K, Tobe T. Nakanishi M, et al. Among authors: okino t. Biotherapy. 1990;2(1):21-32. doi: 10.1007/BF02172073. Biotherapy. 1990. PMID: 2119201

6

The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from breast cancer.

Okino T, Kan N, Nakanishi M, Satoh K, Mise K, Teramura Y, Yamasaki S, Hori T, Kodama H, Ohgaki K, et al. Okino T, et al. J Cancer Res Clin Oncol. 1990;116(2):197-202. doi: 10.1007/BF01612677. J Cancer Res Clin Oncol. 1990. PMID: 2324164

7

[Adoptive immunotherapy against peritoneal metastases from stomach cancer--application of regional lymph node lymphocytes].

Okino T, Kan N, Mise K, Nakanishi M, Satoh K, Yamasaki S, Teramura Y, Inoue K, Ohgaki K, Tobe T. Okino T, et al. Nihon Gan Chiryo Gakkai Shi. 1990 Mar 20;25(3):613-20. Nihon Gan Chiryo Gakkai Shi. 1990. PMID: 2351854 Japanese.

8

[Experimental study on the optimal treatment schedule for combination of BRM (immunostimulators, cultured killer cells or interleukin-2) and chemotherapy].

Kan N, Okino T, Satoh K, Mise K, Teramura Y, Yamasaki S, Harada T, Ohgaki K, Tobe T. Kan N, et al. Among authors: okino t. Gan To Kagaku Ryoho. 1990 Aug;17(8 Pt 1):1421-7. Gan To Kagaku Ryoho. 1990. PMID: 2389941 Japanese.

9

Effect of heat treatment on tumor cells and antitumor effector cells.

Mise K, Kan N, Okino T, Nakanishi M, Satoh K, Teramura Y, Yamasaki S, Ohgaki K, Tobe T. Mise K, et al. Among authors: okino t. Cancer Res. 1990 Oct 1;50(19):6199-202. Cancer Res. 1990. PMID: 2400985

10

Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytoma.

Kan N, Okino T, Nakanishi M, Sato K, Mise K, Yamasaki S, Teramura Y, Ohgaki K, Tobe T. Kan N, et al. Among authors: okino t. Biotherapy. 1989;1(3):197-206. doi: 10.1007/BF02170888. Biotherapy. 1989. PMID: 2642023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters